Proof of Concept Grant

We are excited to announce that Exactmer has been awarded Proof of Concept funding from the European Research Council (ERC), as part of the EU’s research and innovation programme Horizon 2020.

Exactmer will use this research grant, worth €150,000, to fund a 18-month research project to demonstrate that its technology can unlock the tremendous potential of oligonucleotide therapies through dramatically reducing manufacturing costs and increasing production capacity.

This research grant will help us to move our ground-breaking technology towards commercialisation.

The full press release is available here.